Censoring (clinical trials)
- Censoring (clinical trials)
The term censoring is used in clinical trials to refer to mathematically removing a patient from the survival curve at the end of their follow-up time. Censoring a patient will reduce the sample size for analyzing after the time of the censorship. Reducing the sample size always reduces reliability, so the more patients are censored and the earlier they are censored the more unreliable the results are.Fact|date=July 2008dubious
Many clinical trials are designed with a minimum follow-up time. This means that the results aren't reported until that amount of the time after the last patient signed up for the trial. Often reports of the preliminary results don't include any minimum follow-up time and include the patients with very short follow-up time which definitely affects the reliability of the result.
References
* AR Waladkhani. (2008). "Conducting clinical trials. A theoretical and practical guide".ISBN 9783940934000
Wikimedia Foundation.
2010.
Look at other dictionaries:
List of clinical research topics — Clinical research is the aspect of biomedical research that addresses the assessment of new pharmaceutical and biological drugs, medical devices and vaccines in humans. Contents 1 General topics 2 Drug terminology 3 T … Wikipedia
Survival analysis — is a branch of statistics which deals with death in biological organisms and failure in mechanical systems. This topic is called reliability theory or reliability analysis in engineering, and duration analysis or duration modeling in economics or … Wikipedia
Crossover study — A crossover study (also referred to as a crossover trial) is a longitudinal study in which subjects receive a sequence of different treatments (or exposures). While crossover studies can be observational studies, many important crossover studies… … Wikipedia
Criticism of the Food and Drug Administration — Numerous governmental and non governmental organizations have criticized the U. S. Food and Drug Administration of either over or under regulation. The U.S. Food and Drug Administration (FDA) is an agency of the United States Department of Health … Wikipedia
Kaplan–Meier estimator — The Kaplan–Meier estimator,[1][2] also known as the product limit estimator, is an estimator for estimating the survival function from life time data. In medical research, it is often used to measure the fraction of patients living for a certain… … Wikipedia
Logrank test — In statistics, the logrank test is a hypothesis test to compare the survival distributions of two samples. It is a nonparametric test and appropriate to use when the data are right skewed and censored (technically, the censoring must be non… … Wikipedia
Accelerated failure time model — In the statistical area of survival analysis, an accelerated failure time model (AFT model) is a parametric model that provides an alternative to the commonly used proportional hazards models. Whereas a proportional hazards model assumes that the … Wikipedia
